# Hawkhill Therapeutics (Hawkhill Therapeutics Limited)

Private limited company registered in Dundee, classed under “Research and experimental development on biotechnology”.

- Company number: SC853473
- Status: Active
- Type: Private limited company
- Incorporated: 25 June 2025
- Registered office: Life Sciences Innovation Hub, 5 James Lindsay Place, Dundee, DD1 5JJ
- Location: Dundee
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Hawkhill Therapeutics do?

Private limited company registered in Dundee, classed under “Research and experimental development on biotechnology”.

### How much turnover does Hawkhill Therapeutics make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/hawkhill-therapeutics-sc853473

### Is Hawkhill Therapeutics profitable?

Hawkhill Therapeutics's profit isn't public: small companies may file without a profit and loss account.

### How many people work at Hawkhill Therapeutics?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/hawkhill-therapeutics-sc853473

### Who runs and owns Hawkhill Therapeutics?

Its directors are Mbm Secretarial Services Limited, Antoine Boulanger, Mary Canning, Francisca Peixoto, Timothy Jason Sparey and 1 more. Its owners are shown to subscribers.

### Where is Hawkhill Therapeutics based?

Its registered office is Life Sciences Innovation Hub, 5 James Lindsay Place, Dundee, DD1 5JJ, in Dundee.

### When was Hawkhill Therapeutics founded?

Hawkhill Therapeutics Limited was incorporated on 25 June 2025.

### Is Hawkhill Therapeutics still trading?

The register lists Hawkhill Therapeutics Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-09-08: Statement of capital following an allotment of shares on 7 September 2026 · GBP 807.722 (and 2 more like it since 9 April 2026)
- 2026-07-04: Unaudited abridged accounts made up to 31 December 2025
- 2026-06-19: Replacement Filing for the appointment of Mr Antoine Boulanger as a director
- 2026-05-29: Replacement Filing for the appointment of Dr Francisca Peixoto as a director
- 2026-04-14: Satisfaction of charge SC8534730001 in full
- 2026-04-09: Termination of appointment of Sunil Rajen Shah as a director on 30 March 2026
- 2026-04-09: Notification of a person with significant control statement
- 2026-04-09: Cessation of Christopher Andrew Woodland as a person with significant control on 7 April 2026
- 2026-04-09: Appointment of Dr Francisca Peixoto as a director on 30 March 2026
- 2026-04-09: Appointment of Dr Mary Canning as a director on 30 March 2026
- 2026-04-09: Appointment of Mr Antoine Boulanger as a director on 30 March 2026
- 2026-04-09: Memorandum and Articles of Association
- 2026-04-09: Resolutions (and 1 more like it since 8 April 2026)
- 2025-11-10: Registered office address changed from 15 Luke Place Broughty Ferry Dundee DD5 3BN United Kingdom to Life Sciences Innovation Hub 5 James Lindsay Place Dundee DD1 5JJ on 10 Nove…
- 2025-07-16: Registration of charge SC8534730001, created on 4 July 2025
- 2025-07-07: Current accounting period shortened from 30 June 2026 to 31 December 2025
- 2025-06-25: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/hawkhill-therapeutics-sc853473